Other OTC Pharmaceuticals (Pharmacies) - Bosnia and Herzegovina

  • Bosnia and Herzegovina
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$27.31m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.75%, resulting in a market volume of US$28.35m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$8.55 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Bosnia and Herzegovina is experiencing significant growth and development. Customer preferences, market trends, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences in Bosnia and Herzegovina are shifting towards self-medication and over-the-counter (OTC) pharmaceuticals. This can be attributed to several factors, including the convenience and accessibility of OTC products, as well as the increasing awareness and knowledge of consumers regarding their own health and well-being. Additionally, the rising healthcare costs and long waiting times for doctor appointments are leading consumers to seek alternative solutions for minor ailments and common health issues. The market trends in the Other OTC Pharmaceuticals (Pharmacies) sector in Bosnia and Herzegovina are also playing a crucial role in its development. The increasing number of pharmacies and drugstores across the country is indicative of the growing demand for OTC products. These establishments are expanding their product offerings to cater to the diverse needs of consumers, including a wide range of OTC medicines, vitamins, supplements, and personal care products. Furthermore, the emergence of online pharmacies and e-commerce platforms is providing consumers with convenient access to OTC products, further driving market growth. Local special circumstances in Bosnia and Herzegovina are also contributing to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a well-established healthcare system, with a strong emphasis on primary care and community pharmacies. This infrastructure provides a solid foundation for the growth of OTC pharmaceuticals, as consumers have easy access to these products through their local pharmacies. Additionally, the government has implemented regulations and policies to ensure the quality and safety of OTC products, further instilling confidence in consumers. Underlying macroeconomic factors are also playing a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Bosnia and Herzegovina. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income and consumer spending. This, in turn, has fueled the demand for OTC pharmaceuticals, as consumers have more financial resources to allocate towards their healthcare needs. Furthermore, the aging population in Bosnia and Herzegovina is also contributing to the growth of the market, as older individuals tend to rely more on OTC products for their healthcare needs. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Bosnia and Herzegovina is experiencing significant growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the expansion of pharmacies and drugstores, the emergence of online pharmacies, and the country's well-established healthcare system are all contributing to the positive trajectory of the market. Additionally, the steady economic growth and aging population in Bosnia and Herzegovina are further fueling the demand for OTC pharmaceuticals.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)